课题基金 / 基金详情

ENDOTHELIAL CELL RESPONSES TO SHOCK AND TRAUMA

ENDOTHELIAL CELL RESPONSES TO SHOCK AND TRAUMA
内皮细胞对电击和创伤的反应
批准号:
2593086
负责人:
JOHN Marshall HARLAN
金额:
$26.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-05-01 至 2001-04-30

项目摘要

项目成果

JOHN Marshall HARLAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Ischemic (hypoxic) cell injury underlies tissue damage in diverse clinical disorders. Increasing evidence indicates that additional tissue damage follows reoxygenation (reperfusion) of ischemic tissue. Cell death following ischemia may involve activation of a intrinsic cell [suicide] program leading to apoptosis. Reperfusion injury may result from activation of an inflammatory cascade, triggered by signals generated by ischemia or following reperfusion, leading to apoptosis. Understanding the molecular basis of cellular activation/apoptosis in hypoxia/reoxygenation injury may suggest new approaches to therapy of the associated major clinical disorders. The applicant postulates that there are several signaling pathways involved in the endothelial cell s response to hypoxia/reoxygenation. The applicant hypothesizes that the stress-activated protein kinase and p38 kinase (SAPK/p38) pathways are involved in the activation of pro-inflammatory responses, and, along with p53 protein promote apoptosis. In contrast, the NF-kB pathway is required for the induction of cytoprotective pathways that is anti- apoptotic as well as pro-inflammatory. The applicant suggests that the SAPK/p38 pathways or the p53 protein may be an attractive target for hypoxia/reoxygenation induced injury, where as inhibition of the NF-kB signaling pathway alone may compromise endothelial cell survival by preventing the induction of cytoprotective proteins. The overall goal of this application is to elucidate the pathways and genes that promote survival and those that activate pro-inflammatory or pro-apoptotic responses in endothelial cells during hypoxia/reoxygenation. The specific aims in this proposal are thus: 1. to determine the expression and regulation of cytoprotective proteins in endothelial cells during hypoxia/reoxygenation; 2. to determine the role of NF-kB in the induction of pro-inflammatory and cytoprotective genes in endothelial cells during hypoxia/reoxygenation; 3. to define the role of SAPK/p35 kinase pathways in pro-inflammatory and pro-apoptotic responses to endothelial cells in hypoxia/reoxygenation; 4. to determine the mechanisms that regulate interleukin-8 gene expression in endothelial cells during hypoxia/reoxygenation; and 5. to determine the role of the p53 protein in hypoxia induced endothelial cell apoptosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Endothelial Toll-Like Receptor-4 Signaling in Sepsis
  • 批准号:
    7031621
  • 项目类别:
  • 资助金额:
    $22.21万
  • 财政年份:
    2005
  • 负责人:
    JOHN Marshall HARLAN
  • 依托单位:
Endothelial Toll-Like Receptor-4 Signaling in Sepsis
  • 批准号:
    7418682
  • 项目类别:
  • 资助金额:
    $21.56万
  • 财政年份:
    2005
  • 负责人:
    JOHN Marshall HARLAN
  • 依托单位:
Macrophage Apoptosis in Atherogenesis
  • 批准号:
    6905206
  • 项目类别:
  • 资助金额:
    $37.9万
  • 财政年份:
    2005
  • 负责人:
    JOHN Marshall HARLAN
  • 依托单位:
Macrophage Apoptosis in Atherogenesis
  • 批准号:
    7039213
  • 项目类别:
  • 资助金额:
    $37.01万
  • 财政年份:
    2005
  • 负责人:
    JOHN Marshall HARLAN
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: